Clinical Trial Update: A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated adding Avastin (bevacizumab) to a chemotherapy regimen for metastatic pancreatic cancer; the study completed and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-08-13